Nautilus Biotechnology Q1 2024 GAAP EPS $(0.15) Beats $(0.17) Estimate
Nautilus Biotechnology Q1 2024 GAAP EPS $(0.15) Beats $(0.17) Estimate
Nautilus Biotechnology 2024年第一季度GAAP每股收益美元（0.15）超过了美元（0.17）的预期
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 25 percent decrease over losses of $(0.12) per share from the same period last year.
鹦鹉螺生物技术（纳斯达克股票代码：NAUT）公布的季度亏损为每股0.15美元，比分析师普遍预期的0.17美元（0.17美元）高出11.76％。这比去年同期每股亏损0.12美元（0.12）下降了25％。